Helicobacter pylori infection. Helicobacter pylori [H.pylori] as the cause of diseases classified
Conditions
Interventions
Intervention 1: Intervention: Mixture of. Intervention 2: Control group 1: Mixture of. Intervention 3: Control group 2: Amoxicillin capsule 1 g/bd, Clarithromycin capsule 500 mg/ bd and Pantoprazole t
Treatment - Drugs
Intervention: Mixture of
Control group 1: Mixture of
Control group 2: Amoxicillin capsule 1 g/bd, Clarithromycin capsule 500 mg/ bd and Pantoprazole tablet 20 mg/bd by mouth for 14 days. Amoxicillin of Farabi company and clarithromycin and pantoprazole
Sponsors
Research Institute for Islamic and Complementary Medicine, Tehran Unive
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 20-60 years old, documented helicobacter pylori infection and functional dyspepsia. Exclusion criteria: pregnancy, breast feeding, duodenal or gastric ulcer, cancer or bleeding, usage of NSAIDs, corticosteroids, bismuth, antibiotics, proton pomp inhibitors and anticoagulants 4 weeks before the study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Dyspepsia. Timepoint: Six weeks after beginning of intervention. Method of measurement: Dyspepsia questionnaire. | — |
Primary
| Measure | Time frame |
|---|---|
| Helicobacter pylori infection. Timepoint: Six weeks after beginning of intervention. Method of measurement: Urea Breath Test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFataneh Hashem Dabaghian
Research Institute for Islamic and Complementary Medicine, Tehran University of Medical Sciences
Outcome results
None listed